Eli Lilly forecast better-than-expected revenue and adjusted profit for 2019, as the drugmaker benefits from higher demand for its newer medicines including diabetes drug Trulicity and psoriasis drug Taltz.
from Earnings https://ift.tt/2AaBmWj
via IFTTT
No comments:
Post a Comment